Highlights from the 7th Cachexia Conference: muscle wasting pathophysiological detection and novel treatment strategies (Q37635897)

21 August 2017

0 references

Highlights from the 7th Cachexia Conference: muscle wasting pathophysiological detection and novel treatment strategies (English)

1 reference

21 August 2017

1 reference

5

Stephan von Haehling

1 reference

21 August 2017

4

Stefan D Anker

1 reference

21 August 2017

3

Wolfram Doehner

1 reference

21 August 2017

2

Lisa Steinbeck

1 reference

21 August 2017

Nicole Ebner

1

1 reference

21 August 2017

5 March 2014

1 reference

Journal of Cachexia, Sarcopenia and Muscle

21 August 2017

1 reference

21 August 2017

5

1 reference

21 August 2017

1

1 reference

21 August 2017

27-34

1 reference

Mitochondrial dysfunction and sarcopenia of aging: from signaling pathways to clinical trials

21 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3953317

Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3953317

TGF-b superfamily cytokine MIC-1/GDF15 is a physiological appetite and body weight regulator

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3953317

Recent developments in the treatment of cachexia: highlights from the 6th Cachexia Conference

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3953317

The ACT-ONE trial, a multicentre, randomised, double-blind, placebo-controlled, dose-finding study of the anabolic/catabolic transforming agent, MT-102 in subjects with cachexia related to stage III and IV non-small cell lung cancer and colorectal c

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3953317

The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3953317

Diabetes mellitus, cachexia and obesity in heart failure: rationale and design of the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF)

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3953317

Cachexia: a new definition

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3953317

Muscle wasting in heart failure: An overview

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3953317

Mechanism and novel therapeutic approaches to wasting in chronic disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3953317

Formoterol in the treatment of experimental cancer cachexia: effects on heart function

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3953317

Longitudinal changes in total body creatine pool size and skeletal muscle mass using the D3-creatine dilution method

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3953317

Resting energy expenditure and the effects of muscle wasting in patients with chronic heart failure: results from the Studies Investigating Comorbidities Aggravating Heart Failure (SICA-HF).

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3953317

Prevalence of sarcopenia in community-dwelling Japanese older adults

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3953317

Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF).

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3953317

Elevated levels of a C-terminal agrin fragment identifies a new subset of sarcopenia patients

1 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24595460

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Abstracts of the 7th cachexia conference, kobe/osaka, Japan, december 9-11, 2013

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24595460

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Evaluation of C-terminal Agrin Fragment as a marker of muscle wasting in patients after acute stroke during early rehabilitation

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24595460

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S13539-014-0136-Z

1 reference

21 August 2017

1 reference

PMC publication ID

3953317

21 August 2017

PubMed publication ID

24595460

1 reference

PMC publication ID

3953317